Alistair Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Alistair Capital Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-215,900	Closed	-$1.7M	–	22
2014 Q2	$1.7M	Sell	215,900 -346,800	-62%	-$2.62M	1%	18
2014 Q1	$4.45M	Sell	562,700 -354,700	-39%	-$2.85M	1.8%	13
2013 Q4	$5.71M	Buy	+917,400	New	+$4.81M	2.56%	10

Other funds holding CORV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Alistair Capital Management's CORV Position: Q3 2014 in Review

Alistair Capital Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2014, closing a stake of 215,900 shares — an estimated $1.7M sold.

Alistair Capital Management first reported a position in CORV in Q4 2013 and held it in 3 quarters. The position peaked at $5.71M in Q4 2013. 27 funds tracked by Wall St. Rank hold CORV as of Q3 2014.

Alistair Capital Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2014 after selling out during the quarter.
Alistair Capital Management sold 215,900 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q3 2014, an estimated $1.7M.
Alistair Capital Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2013 and held it in 3 quarters.
Alistair Capital Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $5.71M in Q4 2013.
27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2014.

Based on Alistair Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.